SV2002000466A - Combinaciones de carboxialquileter-inhibidor de acat - Google Patents
Combinaciones de carboxialquileter-inhibidor de acatInfo
- Publication number
- SV2002000466A SV2002000466A SV2001000466A SV2001000466A SV2002000466A SV 2002000466 A SV2002000466 A SV 2002000466A SV 2001000466 A SV2001000466 A SV 2001000466A SV 2001000466 A SV2001000466 A SV 2001000466A SV 2002000466 A SV2002000466 A SV 2002000466A
- Authority
- SV
- El Salvador
- Prior art keywords
- acat
- carboxialquileter
- formula
- rent
- inhibitor combinations
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCION ES UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UN CARBOXIALQUILETER QUE REDUCE TRIGLICERIDOS Y LDL Y ELEVA EL HDL Y UN INHIBIDOR DE ACAT QUE MEJORA LA DISLIPIDEMIA EN MAMIFEROS, DICHA COMPOSICION ES UTIL PARA TRATAR LA DISLIPIDEMIA Y SINDROMES ISQUEMICOS Y PARA PREVENIR O RETARDAE EL COMIENZO DE ATAQUES CARDIACOS.LOS CARBOXIALQUIETERES TIENEN LA FORMULA 8 VER FORMULA), EN DONDE Y1 E Y2 INCLUYEN COOH, R1, R2, R3 Y R4 PUEDEN SER ALQUILO, Y N Y M SON NUMEROS ENTEROS DE 2 A 9; Y LOS INHIBIDORES DE ACAT TIENEN LA FORMULA ( VER FORMULA ), EN DOENDE R ES HIDROGENO, X ES O, R1 Y R2 SON FENILO SUSTITUIDO, E Y ES ALQUILO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21005600P | 2000-06-07 | 2000-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2002000466A true SV2002000466A (es) | 2002-04-03 |
Family
ID=22781424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2001000466A SV2002000466A (es) | 2000-06-07 | 2001-05-24 | Combinaciones de carboxialquileter-inhibidor de acat |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1292363A2 (es) |
| JP (1) | JP2003535125A (es) |
| AR (1) | AR034255A1 (es) |
| AU (1) | AU2001263003A1 (es) |
| BR (1) | BR0111428A (es) |
| CA (1) | CA2413906A1 (es) |
| GT (1) | GT200100106A (es) |
| MX (1) | MXPA02010762A (es) |
| PA (1) | PA8518601A1 (es) |
| PE (1) | PE20020265A1 (es) |
| SV (1) | SV2002000466A (es) |
| TN (1) | TNSN01085A1 (es) |
| UY (1) | UY26752A1 (es) |
| WO (1) | WO2001093845A2 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7387236B2 (en) | 2001-10-09 | 2008-06-17 | Delaware Capital Formation, Inc. | Dispensing of currency |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU762124B2 (en) * | 1998-01-28 | 2003-06-19 | Warner-Lambert Company | Method for treating Alzheimer's disease |
-
2001
- 2001-05-08 MX MXPA02010762A patent/MXPA02010762A/es not_active Application Discontinuation
- 2001-05-08 JP JP2002501418A patent/JP2003535125A/ja active Pending
- 2001-05-08 AU AU2001263003A patent/AU2001263003A1/en not_active Abandoned
- 2001-05-08 CA CA002413906A patent/CA2413906A1/en not_active Abandoned
- 2001-05-08 EP EP01937250A patent/EP1292363A2/en not_active Withdrawn
- 2001-05-08 WO PCT/US2001/014804 patent/WO2001093845A2/en not_active Ceased
- 2001-05-08 BR BR0111428-0A patent/BR0111428A/pt not_active IP Right Cessation
- 2001-05-24 SV SV2001000466A patent/SV2002000466A/es not_active Application Discontinuation
- 2001-06-05 PA PA20018518601A patent/PA8518601A1/es unknown
- 2001-06-05 TN TNTNSN01085A patent/TNSN01085A1/en unknown
- 2001-06-05 UY UY26752A patent/UY26752A1/es not_active Application Discontinuation
- 2001-06-05 GT GT200100106A patent/GT200100106A/es unknown
- 2001-06-05 PE PE2001000517A patent/PE20020265A1/es not_active Application Discontinuation
- 2001-06-06 AR ARP010102688A patent/AR034255A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT200100106A (es) | 2002-05-20 |
| JP2003535125A (ja) | 2003-11-25 |
| CA2413906A1 (en) | 2001-12-13 |
| EP1292363A2 (en) | 2003-03-19 |
| BR0111428A (pt) | 2003-06-10 |
| AU2001263003A1 (en) | 2001-12-17 |
| PA8518601A1 (es) | 2002-07-30 |
| TNSN01085A1 (en) | 2005-11-10 |
| AR034255A1 (es) | 2004-02-18 |
| MXPA02010762A (es) | 2003-03-10 |
| WO2001093845A3 (en) | 2002-10-10 |
| WO2001093845A2 (en) | 2001-12-13 |
| UY26752A1 (es) | 2001-07-31 |
| PE20020265A1 (es) | 2002-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP024382A (es) | Inhibidores de proteasa de serina | |
| PA8513601A1 (es) | Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa | |
| UY26864A1 (es) | Composiciones farmaceúticas de inhibidores de la proteína de transferencia de colesteril éster | |
| PE20020521A1 (es) | Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas | |
| EA200201252A1 (ru) | Соединения, эффективные в качестве агонистов э2 - адренорецептора и ингибиторов фосфодиэстеразы pde4 | |
| EA200300906A1 (ru) | Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7 | |
| BRPI0413363A (pt) | formas de dosagem fornecendo liberação controlada de inibidores de proteìna de transferência de ésteres de colesterila e liberação imediata de inibidores de hmg-coa redutase | |
| ATE409485T1 (de) | Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend | |
| DK1001930T3 (da) | N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser | |
| PA8585101A1 (es) | Nuevos inhibidores biciclicos de la lipasa sensible a hormonas | |
| HRP20020205B1 (hr) | Disperzijske formulacije koje sadrže inhibitore lipaze | |
| MEP64008A (en) | Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis | |
| PA8586801A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
| NO20040996L (no) | Nye forbindelser og sammensetninger som catepsin-inhibitorer | |
| NO20011017L (no) | Polymeriserings-inhibitering av styren-monomerer | |
| NZ502133A (en) | Method of enhancing bioavailability of fexofenadine and its derivatives | |
| MXPA04001398A (es) | Metodo para el tratamiento y prevencion de dolor e inflamacion con glucosamina y un inhibidor selectivo de ciclooxigenasa-2 y composiciones para el mismo. | |
| SV2002000466A (es) | Combinaciones de carboxialquileter-inhibidor de acat | |
| DE50205129D1 (de) | 8-tetradecenal als duft- oder aromastoff | |
| EA200301101A1 (ru) | Производные пиперазина и их применение в качестве ингибиторов pde4 | |
| AR030853A1 (es) | Composicion plaguicida | |
| NO20025983L (no) | Smertestillende og antiinflammatoriske sammensetninger som inneholder COX-2hemmere | |
| DE60228134D1 (de) | Substituierte hydrazone als hemmer von cyclooxygenase-2 | |
| CR8340A (es) | Pirazolilcarboxanilidas n-sustituidas | |
| FI20031191A7 (fi) | Monoamiinin takaisinoton estäjä |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse |